Combination of Quizartinib and Omacetaxine Mepesuccinate for AML Carrying FLT3-ITD
Clinical trial NCT03135054 · UNKNOWN
Trial details
- NCT number
- NCT03135054
- Sponsor
- The University of Hong Kong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-01
- Primary completion
- 2020-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.